Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
zomedica已經推出了第三款馬匹專用的胰島素檢測試劑，用於Truforma臨床生物傳感器測試平台的馬血漿檢測。
- Veterinarians test equine insulin levels when they suspect Equine Metabolic Syndrome (EMS) or other forms of insulin dysregulation, as frequently occurs with equine Cushing's disease, or Pituitary Pars Intermedia Dysfunction (PPID), with prevalence reported between 18-27% of ponies and horses. Left untreated, laminitis, which can lead to euthanasia, is a consequence of both EMS and PPID.
- The TRUFORMA Insulin assay offers quantitative detection of insulin levels in equine plasma, with results available in just 18 minutes. This rapid turnaround enables veterinarians to diagnose and monitor insulin dysregulation in horses quickly, eliminating the need for reference laboratory wait times and allowing for immediate treatment decisions. The assay is designed for both in-clinic and stall-side use, providing flexibility for various clinical settings. Importantly, Zomedica offers this advanced diagnostic capability with no capital outlay or monthly minimums from veterinary practices.
- 獸醫在懷疑馬代謝綜合症（EMS）或其他形式的胰島素失調時會測試馬的胰島素水平，這種情況經常發生在馬庫欣氏病或垂體間功能障礙（PPID）中，據報道，小馬和馬的患病率在18-27％之間。如果不加以治療，可能導致安樂死的椎板炎是EMS和PPID的後果。
- TRUFORMA 胰島素測定可定量檢測馬血漿中的胰島素水平，僅需 18 分鐘即可得出結果。這種快速的週轉使獸醫能夠快速診斷和監測馬匹的胰島素失調，從而無需參考實驗室等待時間，從而可以立即做出治療決定。該檢測專爲臨床和攤位使用而設計，爲各種臨床環境提供了靈活性。重要的是，Zomedica提供了這種先進的診斷能力，獸醫診所無需資本支出或每月最低限額。
資訊熱榜
更新時間